COVID-19 vaccination before infection cuts risk for long COVID
Nov 27, 2023
COVID-19 vaccination with any number of doses before infection was linked to a reduced risk for post-COVID-19 condition.
Coadministration of COVID-19, influenza vaccines seems effective
Nov 09, 2023
The researchers found that the incidence rates of emergency department or urgent care encounters and outpatient visits were slightly higher for the coadministration group versus the BNT162b2-biv-only group...
Business briefs, Nov. 7
By
Kathleen Steele Gaivin
Nov 07, 2023
“No end in sight” for vaccine challenges … DOL offers webinar to help long-term care employers reduce wage violations … FHA proposes changes to reverse mortgage program … Minimum staff proposal...
Bill would ban COVID-19 vaccine mandates despite older adults remaining at highest risk for serious outcomes
By
Kimberly Bonvissuto
Nov 02, 2023
A study underscoring the need to continue to protect older adults from COVID-19 comes as one state appears close to banning COVID-19 vaccine mandates by private employers, including senior living communities.
Medicare drug price negotiations: A game-changer for seniors’ healthcare
By
Luka Yancopoulos
Nov 02, 2023
The relatively recent passage of the Inflation Reduction Act, which among other provisions, allows Medicare to negotiate prescription drug prices, marks a monumental shift in senior healthcare in America.
Vaccination for senior living residents hindered by access issues, fatigue, misinformation
By
Kimberly Bonvissuto
Nov 01, 2023
Vaccine uptake by senior living residents is being hampered by barriers to access, vaccine fatigue and misinformation, according to two providers.
At-home, inhaled flu vaccine could be on horizon
Oct 31, 2023
AstraZeneca is asking the FDA to allow adults aged 18 to 49 years to be able to give themselves the vaccine or give it to children aged 2 to 17 years.
Just 7 percent of US adults have gotten updated COVID-19 vaccine
Oct 27, 2023
The new shot targets a highly contagious variant that is in wide circulation nationwide.
Positive link identified between SARS-CoV-2 and Guillain-Barré
Oct 18, 2023
Odds ratio of 6.30 for Guillain-Barré syndrome association with SARS-CoV-2 infection and 0.41 for COVID-19 vaccine administration.